Related Experiment Video
Updated: Apr 15, 2026
06:30
Complete and Partial Resuscitative Endovascular Balloon Occlusion of the Aorta for Hemorrhagic Shock
Published on: May 19, 2022
8.4K
Contemporary management of blunt aortic trauma
J J Dubose1, A Azizzadeh, A L Estrera
1Department of Cardiothoracic and Vascular Surgery, University of Texas Houston Medical Schoolin Houston and Memorial Hermann Heart and Vascular Institute, Houston, TX, USA - Joseph.J.DuBose@uth.tmc.edu.
The Journal of Cardiovascular Surgery
|April 15, 2015
Summary
Blunt thoracic aortic injury (BTAI) treatment has improved survival. Key areas like patient selection, treatment timing, and long-term follow-up for BTAI require further research and collaboration.
Area of Science:
- Trauma Surgery
- Vascular Surgery
- Emergency Medicine
Background:
- Blunt thoracic aortic injury (BTAI) is a frequent cause of mortality in trauma.
- Advances in diagnosis and treatment have improved survival rates for BTAI patients.
- Current management is guided by Society for Vascular Surgery (SVS) guidelines.
Purpose of the Study:
- To address persistent controversies in optimal BTAI care.
- To highlight areas needing further investigation, including selection criteria and treatment timing.
- To introduce the Aortic Trauma Foundation (ATF) as a collaborative research initiative.
Main Methods:
- Review of current literature and clinical practice regarding BTAI.
- Analysis of existing Society for Vascular Surgery (SVS) guidelines.
- Discussion of emerging research areas and the role of the Aortic Trauma Foundation (ATF).
Main Results:
- Significant progress has been made in BTAI diagnosis and treatment.
- Controversies persist regarding optimal patient selection and treatment timing.
- The need for long-term follow-up data remains critical.
Conclusions:
- While survival has improved, optimal BTAI management requires further refinement.
- Collaborative research through initiatives like the Aortic Trauma Foundation (ATF) is essential.
- Future research should focus on selection criteria, treatment timing, and long-term outcomes for BTAI.
Related Concept Videos
01:22Aneurysm IV: Nursing Management
600
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
600
01:26Aneurysm III: Interprofessional Care
460
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
460
01:26Flail Chest-II
929
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
929
01:28Acute Coronary Syndrome IV: Interprofessional Care
493
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
493
01:26Angina IV: Management
441
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
441
01:25Aortic Regurgitation III: Medical Management
562
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
562